{"transactions":[{"id":2688870,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":138814,"kind":"person","name":"Widlitz Michael","position":1,"cik":"0001826907","reported_name":"Widlitz Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-02T00:00:05.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest 25% every quarter after the grant date."}],"balance_after":3750,"derivative":{"exercise_price":20.92,"expiration_date":"2031-05-28","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001104659-21-075258","document":"tm2118079-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465921075258/tm2118079-10_4seq1.xml","form_type":"4"}},{"id":2991038,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":138814,"kind":"person","name":"Widlitz Michael","position":1,"cik":"0001826907","reported_name":"Widlitz Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-06T01:20:19.000Z","date":"2020-11-03","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"One-twelfth (1/12th) of the shares subject to the option shall vest on February 3, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest every three months thereafter."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth (1/12th) of the shares subject to the option shall vest on February 3, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest every three months thereafter."}],"balance_after":7500,"derivative":{"exercise_price":11.38,"expiration_date":"2030-11-03","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-20-122037","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465920122037/a4.xml","form_type":"4"}},{"id":3010006,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":138814,"kind":"person","name":"Widlitz Michael","position":1,"cik":"0001826907","reported_name":"Widlitz Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-10-08T22:17:51.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":51315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":51315},"source":{"system":"sec-edgar","filing":"0001209191-20-054319","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919120054319/doc4.xml","form_type":"4"}},{"id":3010005,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":138814,"kind":"person","name":"Widlitz Michael","position":1,"cik":"0001826907","reported_name":"Widlitz Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-08T22:17:51.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":51315,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."}],"balance_after":51315,"source":{"system":"sec-edgar","filing":"0001209191-20-054319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919120054319/doc4.xml","form_type":"4"}}]}